NAMDC: Exploring the Clinical Utility of Growth Differentiation Factor 15 as a Biomarker for Primary Mitochondrial Disorders

Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the North American Mitochondrial Disease Consortium (NAMDC). This summary is based on a paper published in the Journal of Inherited Metabolic Disease on November 24, 2024, titled...
show moreRead the paper here: https://onlinelibrary.wiley.com/doi/10.1002/jimd.12821
Learn more about NAMDC: https://namdc.rarediseasesnetwork.org
Information
Author | RDCRN |
Organization | RDCRN |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments